Škof, E., & Krajc, M. (2016). Lynparzatm (olaparib): new medicine for targeted therapy of ovarian cancer. Onkologija : Slovenian Journal of Oncology, 20(1), 12–14. Retrieved from https://revijaonkologija.si/Onkologija/article/view/60